chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This is a spontaneous report received from a contactable consumer (patient) reported for herself. A 31-year-old female patient received the 2nd dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, solution for injection, batch/lot# unknown), via an unknown route of administration, on an unknown date, single dose, for COVID-19 immunization. Facility where the most recent COVID-19 vaccine administered reported as other. The patient's medical history and concomitant medications  not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. The patient received her 2nd dose of the Pfizer-BioNTech COVID-19. When the nurse pulled out the needle, a stream of blood (quite a bit of blood) came out. She now has a hard lump there. The outcome of events: unknown. No follow-up attempts possible. Information about lot/batch number cannot be obtained.
11/8/21  Pre admission testing for surgery on 11/11/21, abscess of foot, right great toe amputation
reaction to covid vaccine: 4/7/2021 - Moderna, Left deltoid Approx. 4/13/2021 @ 11am : noticed red, small dot rash on bilateral forearms. @ 6:20pm patient went to Urgent Care due to the rash had spread to neck and bilateral arms. Nurse Practitioner advised patient that it could be a reaction to the COVID vaccine, since it was the only change. Was given Benadryl Shot @ 7:02pm and oral pepcid @ 7:03pm. Approx. @1am on 4/14/2021 patient began getting itching and took two tablets of Benadryl. Woke up on 4/14/2021 @ 7:30am and noticed the rash/red bumps had spread over her entire body. RASH DOES NOT ITCH. Occasional burn but very rare.
administered above the deltoid region of upper arm / which caused pain; administered above the deltoid region of upper arm; This case was reported by a consumer and described the occurrence of injection site pain in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, immediately after receiving Shingrix, the patient experienced injection site pain and vaccine administered at inappropriate site. On an unknown date, the outcome of the injection site pain and vaccine administered at inappropriate site were unknown.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.  Additional details were provided as follows: The patient reported the case for herself. The age at vaccination was not reported for 1st dose and not applicable for 2nd dose. The patient received first shot of Shingrix and patient believed the vaccine was administered above the deltoid region of upper arm (possible vaccine administered at Inappropriate Site) which caused pain and led to vaccine administered at inappropriate site. The patient stated that, she was due for her second dose of Shingrix vaccine. The reporter was asking questions to collect information from the patient to submit adverse event to safety but the patient kept denying to answer the questions indirectly by saying okay, that all I needed or okay, well thank you for the information.reporter tried twice to obtain required information to file adverse event. The reporter could not collect patient's full address, phone number, and an email address. also, could not collect  health care professional contact information, date of birth, lot number, expiry date date, dose, date of administration, left/right arm, date of the first dose of Shingrix, how soon did the symptom (pain) start after the shot, and if the symptom has been resolved. The patient did provide consent to follow-up and also did not provide any contact information of health care professional.
Sore Arm after first dose of Covid Vaccine; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient received bnt162b2 (BNT162B2, Solution for injection, Lot Number: EW0176, expiry date: unknown) dose 1 via an unspecified route of administration, administered in right arm on 29Apr2021 as single dose for COVID-19 immunisation. The patient took Covid Pfizer Vaccine because she wanted to travel. The patient medical history and concomitant medication were not reported. Prior Vaccinations within four weeks prior to the first administration date of the suspect vaccine was reported as none. Additional Vaccines administered on same date of the Pfizer Suspect was reported as none. Any adverse events following prior vaccinations was reported as none. Any illness at the time of vaccination was reported as none. On 30Apr2021, the patient experienced sore arm the next day after the first dose of the vaccine, but then it was gone. The outcome of the event was recovered on 01May2021.  No follow-up attempts possible. No further information is expected.
No adverse etfects reported; patient received improperly stored dose of MMR II; This spontaneous report was received from a nurse and refers to a 12-months-old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 16-JUL-2019, the patient was vaccinated with an improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) lot # R024905, expiration date 30-AUG-2020, albumin status rHA (dose and route of administration were not reported). There was no adverse effect reported. Administered dose of vaccine experienced the highest temperature excursion of above 47 degrees Fahrenheit (54 degrees Fahrenheit) for 17 hours and 15 minutes on 12-JUL-2019. Data logger was involved. There were no previous excursions reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1911USA004662:
PATIENT CAME TO HEALTH DEPARTMENT WITH C/O THAT SHE HAD RECEIVED FLU VACCINE GIVEN AT HEALTH DEPARTMENT IN RIGHT ARM ON 12/29/2010. PATIENT STATES SHE HAD SWELLING TO INJECTION SITE ALONG WITH ITCHING AND SWELLING AND SWELLING TO RIGHT SIDE OF NECK. HAD REDNESS TO AREA WITH ITCHING. PATIENT HAS APPLIED ITCHING CREAM TO SITE, HOWEVER STILL ITCHING. NO SOB OR DISTRESS; NURSE INSTRUCTED PATIENT TO SEE PRIVATE DOCTOR.
Developed blood clot in right leg.  Had three thrombectmomys to remove clots at a local HCF.  Clots came back after every operation.
Was administered vaccine of thimersol against my written and oral instructions. Two and half months of Dizziness sore left arm motion memory (which is stored in the hippocampus) was faulty.
I did not have an adverse reaction to the vaccine. I had to go to the emergency room three times in a period of one month. I was admitted for ten days with pancreatitis. I had stents put in and then later removed. I had my gallbladder removed. As of today, I am feeling better but not 100 percent.
it was determined I have Bell's Palsy; This is a spontaneous report received from a contactable consumer (patient).  A 44-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 02May2021 13:00 (Lot number: EW0172) as single dose for (at the age of 44-years-old) COVID-19 immunization. Medical history included diabetes, sleep apnea, high blood pressure, neuropathy. The patient was not pregnant at the time of vaccination. No allergies. Unspecified concomitant medications were taken ("Yes my prescribed medications"). The patient reported that, "My face started getting droopy, my speech slurred and started having extreme facial pain. I went to my Primary Care Physician she did blood work and it was determined I have Bell's Palsy." Date of start of reaction was on 18May2021 07:15. The adverse event resulted in any Doctor or other healthcare professional office/clinic visit. Hospitalization not Prolonged. The outcome of event was not recovered. The event is serious (medically significant). Another dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) was administered via an unspecified route of administration on 23May2021 03:00 PM, administered in Arm Left (Lot number: EW0172) as single dose for COVID-19 immunization (pending clarification).  Facility where the most recent COVID-19 vaccine was administered was in Pharmacy or Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.  Additional information has been requested.
The day I got the vaccine, I waited 15 minutes at the clinic for any immediate adverse reaction.  While driving myself home, I felt this strange sensation of warmth course through my body and immediate light-headedness resulted.  I wondered if I were going to pass out and whether I should pull over.  But I continued driving home and have been light-headed (even dizzy if I move my head too much) since then.  I tried drinking a lot of water, resting, taking an antihistamine and ibuprofen, but none of those changed the way I felt, although it doesn't feel as bad if I am sitting still and lying down.  After six days of no improvement, I went to the doctor (on March 15th), who prescribed meclizine to help with the light-headedness.  They also took blood to check for other possible causes of the light-headedness.  They said the feeling will probably go away, and they gave me a doctor's note indicating that my second does of the vaccine could be Johnson and Johnson, since that is not an mRNA drug .  They said I should wait 28 days at least before getting that.  I will likely wait a little longer than that just to be safe, and I will not even take that if this feeling doesn't go away by then.
She got the vaccine, about 8-10 hours after the vaccine had typical side effects to vaccine site, she got a headache which is normal from vaccines, woke up in the middle of the night with fever.  She wasn't really sick, just exhausted.  No energy at all, and then she got a sore throat, had an earache, kind of a cold symptom reaction which went on for about 7 days, which she thought she was getting a sinus infection.  Just didn't feel good, no appetite, just couldn't function normally.  On the 9th day she woke up and felt good other than the sore arm.  The next day she started noticing that she could not move her fingers as her joints were hurting.   This has spread to her shoulders, feet, toes and most joints which has been continuous since she got the vaccine.  She didn't notice it so much with the 1st one, but she does with this one.  She does not have any swelling of the joints and never has had the pain in her joints like this.  She has been taking Aleve for the pain to be able to function.  She went from feeling like she was 60 to feeling like she is 90.    She has an appointment with her PCP next week.
red round spot on his arm the size of a band aid; sore and achy; tired; blood pressure is low; This is a spontaneous report from non-contactable consumer (Patient). A male patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: unknown) via an unspecified route of administration on 29Mar2021 as single dose for COVID-19 immunisation. The patient medical history was not reported. Concomitant medications were not reported. The patient received first dose of BNT162B2 on an unspecified date. the patient reported that, a month after second dose, still had a red round spot on arm the size of a band aid, and still feels sore, achy, and blood pressure is low. The outcome of the events red round spot on arm, pain, fatigue was not recovered, and blood pressure is low was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
A report was received from a health care professional on 10/3/03 concerning a female vaccinee of unspecified age who experienced confusion and a tingling sensation 1 day after receiving Fluvirin on an unknown date in 2003. On an unspecified date the vaccinee experienced confusion and a tingling sensation all over her body. The confusion and tingling resolved within 24 hours. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
His edema started to get worse; This is a spontaneous report from a contactable consumer (patient's wife). A 53-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection; lot number: EN6208), via an unspecified route of administration, administered in the left arm on 13Mar2021 (at the age of 53-years-old) as dose 1, single for COVID-19 immunization. Medical history included diabetic, hypertension, edema, and allergy to not fresh seafood. The patient received unspecified medications in two weeks prior to the COVID-19 vaccine. The patient did not receive other vaccines within four weeks of the COVID-19 vaccine. The patient's wife reported that after the patient got his first vaccine in March his edema started to get worse. The event was considered life-threatening. On an unspecified date, the patient received the second single dose of BNT162B2 (lot number: ER8737) administered in the left arm. On 02Sep2021, the patient got his third single dose of BNT162B2 (lot number: FC3182) administered in the left arm. Therapeutic measure was not taken as result of the event. The patient underwent lab tests and procedures which included SARS-CoV-2 test (Nasal Swab): negative on 01Sep2021. The outcome of the event was not recovered.
Chest tightness. On the inside , felt like I needed to exhale; administration date=07Jan2021, administration time=02:00 PM, dose number=2/administration date=18Dec2020, administration time=11:00 AM, dose number=1; This is a spontaneous report from a contactable nurse (patient herself). A 42-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL3246; expiry date: unknown) via an unspecified route of administration (left arm), on 07Jan2021 at 14:00 at a single dose, for COVID-19 immunization. Relevant medical history included allergies to penicillin. Concomitant medication included acyclovir (ACYCLOVIR). The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL 0140; expiry date: unknown) in the right arm on 18Dec2020 at 11:00 AM, for COVID-19 immunization. The patient is not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered in the hospital. On 08Jan2021, at 21:00, the patient experienced chest tightness. On the inside, she felt like she needed to exhale. The patient did not receive treatment for the event. Outcome of the event chest tightness was not recovered.
Received HPV IM in left deltoid on 5-7-08. Developed redness, swelling, hot to touch & pain at site and surrounding area. Within a week of administration sought medical treatment for cellulitis at injection site. Treated with antibiotic. Condition resolved. Urgent care treatment was 5/09/08.
Initial unsolicited report received from a nurse on 16-MAR-2017. This case involves a 40-years old male patient who was vaccinated with a dose of ACAM2000 (batch number, expiry date, dose and dose in series were not reported) in an unknown site on 04-AUG-2016. Patient's medical history as pre-existing physician diagnosed allergies, birth defects, medical conditions (specify) was reported as no known allergy (NKA) and Illness at the time of vaccination was reported as not applicable. Any other vaccinations within four weeks of vaccinations were also not reported. Concomitant medications were not reported. On 23-AUG-2016, 19 days of following the vaccination, the patient had developed swelling and pain in left hand, arm and upper extremity. The patient required emergency room (ER) or doctor visit on an unknown date. Laboratory investigations and corrective treatment were not reported. The outcome of event was reported as recovered. List of documents held by sender: none.
Non occlusive thrombus within the left popliteal vein.  Echo genic material along the anterior and posterior of left popliteal vein .  65 year old patient presenting with left posterior knee pain .   Patient has no history of blood clotting or dvt.  Self reported.
Persistent headache (started a few hours after receiving vaccine and has been present off/on throughout the week) Fever (started morning after receiving vaccine, peaked at 103 degrees F, lasted 2 days) Fatigue (started morning after receiving vaccine, sleeping 14-16 hours a day with minimal energy during waking hours)
pt recvd vax & same am exp flu like symptoms; fever of 102; headache & upper respiratory symptoms; was found to have meningitis; 7sep94 flu-like sxs & resp sxs persisted, 8sep94 hosp;
My daughter received her 4 month vaccinations on February 11, 2004. She was given ADPT, HIB, IPV, and Prevnar. A week later she started to exhibit what appeared to be seizures. Her whole body shook for about 20-30 seconds each time. She didn't lose consciousness. She experienced at least 4 episodes. She was referred to a neurologist. 24 hour EEG was normal. She has not had an episode since. No other cause could be found leading the doctor to believe it was related to the Pertussis vaccination. My sister (her aunt) had an adverse reaction to the DPT vaccination as a child.
Is swelling normal after vaccine?; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Is swelling normal after vaccine?) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (Is swelling normal after vaccine?). At the time of the report, VACCINATION SITE SWELLING (Is swelling normal after vaccine?) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Follow-up information received on 25-MAY-2021, contains no new information.
Pt recvd vax & 5 minutes later pt devel induration & erythema which measured 8-10mm; No further details were provided;
Patient had no history of Covid vaccines in EMR and did not have his covid vaccination card with him.  Patient refused to go home and bring back card.  Patient stated he had received a covid vaccine in the past.  Nurse administered a monovalent Pfizer vaccine.  When checking the vaccine log system patient patient had a documented J&J in March 2021.  Patient should have received a bivalent booster dose.
Day 1. After 15 minutes, intense hot flashes, continued all day, Left arm sore, swollen, nausea, slight headache. Day 2. Hot flashes, less intense, nausea, sore throat, slight headache, post nasal drip, slight cough and sneeze, Day 3. Swollen lymph nodes in throat, lost voice, chest sternum pain, slight headache, fatigue (called Dr). Day 4. No voice, body aches, nausea, head ache, chills, body aches, fatigue,post nasal drip, slight cough and sneeze . Day 5, chest and back pain, body aches, nausea, heartburn, still no voice, post nasal drip, slight cough and sneeze, headache, fatigue, chills. Day 6. Worst day of all! Intense headache that did not go away, almost went to Emergency Room, I was too tired to get up from the bed, body aches, chills, fatigue, still no voice, felt awful all day, I could not sleep because of the headache pounding, back hurt, it was painful to sneeze or cough,post nasal drip, slight cough and sneeze.. Day 7, Feeling slightly better, slight headache, body aches, post nasal drip, slight cough and sneeze. Day 8 felt 70% better, voice slightly returning.
This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's concomitant medications, pertinent medical history, concurrent conditions, drug reactions or allergies were not reported. On 14-SEP-2017, the patient was vaccinated with an improperly stored dose of ZOSTAVAX 19400 PFU, lot # N020943, expiration date 26-OCT-2018 (dose and route of administration were not provided) for prophylaxis. The vaccine was reconstituted with a proprly stored dose of  sterile diluent (DILUENT MRK) lot #N016189, expiration date 13-AUG-2019.    On an unspecified date, the vaccine was exposed to temperature ranges between -9° Celcius (C) to 8°C during a time frame of 11 days. There was not previous temperature excursion, the temperature excursion was not called by a data logger. Adverse effects were not reported.
Patient experienced severe headache, body ache, nausea and chills within 24 hours after vaccine.
This lasted for 6 months, with extremely heavy menstruation; I was menopausal,started menstruating. This lasted for 6 months; This is a spontaneous report received from a contactable reporter (Other HCP). The reporter is the patient.  A 50-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 22Feb2021 10:00 (Lot number: EL9266) at the age of 50 years as dose 2, single for covid-19 immunization. Relevant medical history included: "I was menopausal" (unspecified if ongoing), notes: I was menopausal (no periods for over, a year), known allergies: No. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: EL9265, Location of injection: Arm Left, Vaccine Administration Time: 09:30 AM), administration date: 01Feb2021, when the patient was 50 years old, for COVID-19 Immunization, reaction(s): "was menopausal (no periods for over a year), but after the first shot, I felt abdominal pains". The patient didn't receive any other vaccines within 4 weeks prior to the COVID -19 vaccine. The patient didn't receive any other medications within 2 weeks of vaccination.  Prior to vaccination, patient was not diagnosed with COVID-19. After the vaccination patient has not been tested for COVID-19. The following information was reported: HEAVY MENSTRUAL BLEEDING (medically significant) with onset 2021, outcome "recovered" (2021), described as "This lasted for 6 months, with extremely heavy menstruation"; POSTMENOPAUSAL HAEMORRHAGE (medically significant) with onset 2021, outcome "recovered" (2021), described as "I was menopausal, started menstruating. This lasted for 6 months". Therapeutic measures were not taken as a result of heavy menstrual bleeding, postmenopausal hemorrhage.; Sender's Comments: Based on the current available information and a possible contributory role of the suspect product BNT162B2 to the development of events postmenopausal bleeding, heavy menstrual bleeding cannot be totally excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
bilateral lymphadenopathy in axilla and groin regions beginning around 2/22/21 and ongoing. confirmed by NP examination 3/3/2021 - scheduled for follow-up 3/24/2021.  --  Severe flare of eczema during this time, unknown if this was related to vaccinations - treated with IM decadron and IM triamcinolone.
Tested positive for COVID-19 the Wednesday one week after vaccination. Likely exposed to COVID on Monday 3/29/2021.
Shooting pains up and down injection arm for a week. Since day of vax- Forearm twitching in both arms daily. Numerous headaches with light sensitivity.